Global Oncology Trends 2021 Outlook to 2025
Summary
Despite the COVID-19 pandemic having a substantial impact on patient care during 2020, the scientific advances in clinical trial activity, the pipeline of new treatments, and the increased use of available therapeutics, continued largely unaffected and reflect the commitment to advancing care for patients by oncologists, other care providers, governments and payers, and life sciences companies.
Key Findings
Impact of COVID-19 on Cancer Care
The pandemic continues to have a substantial impact on cancer care with oncologist in the US, Japan and Europe reporting caseloads that are 26-51% lower than pre-pandemic levels, delays in necessary treatments, screenings at 11-23% below baseline levels and community oncologists in the US reporting an increasing share of their new patients presenting with metastatic cancer.